Double trouble for the tumour glycocode

<p>Nature Reviews Cancer, Published online: 02 January 2026; <a href="https://www.nature.com/articles/s41568-025-00902-y">doi:10.1038/s41568-025-00902-y</a></p>By incorporating lectins that target specific tumour-associated carbohydrate antigens, Zhou et al. engineered bispecific antibodies that induce effective T cell activation and tumour regression in various cancers.